PerkinElmer, Inc.  

(Public, NYSE:PKI)   Watch this stock  
Find more results for Custom Living, Inc
43.94
-0.50 (-1.13%)
Jan 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 43.69 - 44.36
52 week 38.96 - 48.26
Open 43.89
Vol / Avg. 1.19M/908,307.00
Mkt cap 5.02B
P/E 25.21
Div/yield 0.07/0.64
EPS 1.74
Shares 112.96M
Beta 0.95
Inst. own 96%
Apr 20, 2015
PerkinElmer Annual Shareholder Meeting (Estimated) Add to calendar
Jan 29, 2015
Q4 2014 PerkinElmer Inc Earnings Call - 5:00PM EST - Add to calendar
Jan 29, 2015
Q4 2014 PerkinElmer Inc Earnings Release - 4:00PM EST - Add to calendar
Jan 14, 2015
PerkinElmer Inc at JPMorgan Healthcare Conference
Dec 2, 2014
PerkinElmer Inc at Piper Jaffray Healthcare Conference
Nov 19, 2014
PerkinElmer Inc at Jefferies Global Healthcare Conference - London
Oct 30, 2014
Q3 2014 PerkinElmer Inc Earnings Call - Webcast
Oct 30, 2014
Q3 2014 PerkinElmer Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 7.91% 7.75%
Operating margin 10.84% 10.04%
EBITD margin - 17.62%
Return on average assets 4.40% 4.28%
Return on average equity 8.36% 8.54%
Employees 7,600 -
CDP Score - 62 D

Address

940 WINTER STREET
WALTHAM, MA 2451
United States - Map
+1-781-6635776 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company, through solutions, and services and advanced technologies, is focused on improving the health and safety of people and their environment. The Company�s product line includes Assays and Reagents, Consumables and Accessories, Cord Blood, Flat Panel X-ray Detectors, Instruments, and Software and Informatics. The Company operates in two business segments: Human Health and Environmental Health. The Company provides products and services in approximately 150 countries.

Officers and directors

Robert F. Friel Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank Anders Wilson CPA Chief Financial Officer, Senior Vice President
Age: 55
Bio & Compensation  - Reuters
Daniel R. Marshak Ph.D. Chief Scientific Officer, Senior Vice President, President - Emerging Diagnostics
Age: 56
Bio & Compensation  - Reuters
Joel S. Goldberg Senior Vice President, General Counsel, Secretary
Age: 45
Bio & Compensation  - Reuters
John R. Letcher Senior Vice President - Human Resources
Age: 52
Bio & Compensation  - Reuters
James L. Corbett Senior Vice President, President - Diagnostics
Age: 51
Bio & Compensation  - Reuters
Jon DiVincenzo Senior Vice President, President - Environmental Health
Bio & Compensation  - Reuters
Maurice H. Tenney III Senior Vice President, President - Global Operations and Customer Logistics
Age: 50
Bio & Compensation  - Reuters
Andrew Okun Chief Accounting Officer, Vice President
Age: 44
Bio & Compensation  - Reuters
Nicholas A. Lopardo Lead Independent Director
Age: 67
Bio & Compensation  - Reuters